These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1037361)

  • 61. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bromocriptine--a versatile remedy.
    Joffe BI; Distiller LA; Seftel HC
    S Afr Med J; 1977 Jun; 51(26):954-5. PubMed ID: 578015
    [No Abstract]   [Full Text] [Related]  

  • 64. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 65. [Long-term therapy of acromegaly and gigantism by using CB-154].
    Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M
    Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effect of bromocriptine (CB-154) in diabetes associated with acromegaly].
    Sakai Y; Nagasaka A; Makino H
    Horumon To Rinsho; 1977 Dec; 25(12):1323-6. PubMed ID: 598034
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of different dopaminergic agents in the treatment of acromegaly.
    Colao A; Ferone D; Marzullo P; Di Sarno A; Cerbone G; Sarnacchiaro F; Cirillo S; Merola B; Lombardi G
    J Clin Endocrinol Metab; 1997 Feb; 82(2):518-23. PubMed ID: 9024247
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Letter: Bromocriptine and growth hormone.
    Morgan L; Barrett A; Hobbs JR
    Lancet; 1976 Jan; 1(7952):195. PubMed ID: 54704
    [No Abstract]   [Full Text] [Related]  

  • 69. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Relationship between suppression of growth hormone by CB-154 and prolactin secretion in acromegaly--indication for a long term care].
    Hara I; Kataoka K; Tomita A; Kuwayama A; Kageyama N
    Horumon To Rinsho; 1977 Dec; 25(12):1316-20. PubMed ID: 413675
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of acromegaly using CB-154 and medroxy-progesterone acetate].
    Ichikawa Y; Yoshida K; Kawagoe M
    Horumon To Rinsho; 1977 Dec; 25(12):1303-4. PubMed ID: 598028
    [No Abstract]   [Full Text] [Related]  

  • 72. Bromocriptine suppression of plasma growth hormone in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):273-81. PubMed ID: 336245
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J; Harris AG; Kvistborg A; Kjartansson O; Hanssen E; Smiseth O; Djøsland O; Hass G; Jervell J
    J Clin Endocrinol Metab; 1990 May; 70(5):1254-61. PubMed ID: 2186055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bromocriptine and acromegaly: therapeutic implications.
    Brooks AP; Stephen PJ; Nairn IM; Strong JA
    J R Soc Med; 1979 Aug; 72(8):562-4. PubMed ID: 552555
    [No Abstract]   [Full Text] [Related]  

  • 75. Letter: Bromocriptine and hypertension.
    Kaye SB; Shaw KM; Ross EJ
    Lancet; 1976 May; 1(7970):1176-7. PubMed ID: 58213
    [No Abstract]   [Full Text] [Related]  

  • 76. Letter: Growth-hormone response to bromocriptine in parkinsonism.
    Shaw KM; Lees AJ; Hayes S; Ross EJ; Stern GM; Thompson BD
    Lancet; 1976 Jan; 1(7952):194. PubMed ID: 54702
    [No Abstract]   [Full Text] [Related]  

  • 77. Editorial: Bromocriptine--a changing scene.
    Br Med J; 1975 Dec; 4(5998):667-8. PubMed ID: 1239326
    [No Abstract]   [Full Text] [Related]  

  • 78. Editorial: The many faces of bromocriptine.
    Vaisurb S
    JAMA; 1976 Jun; 235(26):2854-5. PubMed ID: 946996
    [No Abstract]   [Full Text] [Related]  

  • 79. Measurement of the 24 hour integrated plasma concentration of growth hormone, in assessing the response of acromegalic patients to treatment.
    Daggett PR; Nabarro JD
    Clin Endocrinol (Oxf); 1977 Dec; 7(6):437-41. PubMed ID: 563781
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Vascular and extra-cellular volumes in acromegaly (author's transl)].
    Strauch G; Ingrand J; Therain F; Lego A; Pandos P; Roucayrol JC; Bricaire H
    Ann Endocrinol (Paris); 1973; 34(4):405-6. PubMed ID: 4779736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.